Literature DB >> 23364699

Preoperative histological subtype classification of intraductal papillary mucinous neoplasms (IPMN) by pancreatic juice cytology with MUC stain.

Taro Hara1, Dai Ikebe, Akiko Odaka, Kentaro Sudo, Kazuyoshi Nakamura, Hiroshi Yamamoto, Makiko Itami, Tetsushi Hirata, Junya Kashimura, Taketo Yamaguchi.   

Abstract

OBJECTIVE: To prospectively evaluate the diagnostic value of preoperative histological subtyping of intraductal papillary mucinous neoplasms (IPMNs) by pancreatic juice cytology (PJC) with mucin (MUC) stain.
BACKGROUND: IPMNs are classified into four subtypes based on their histomorphology and mucin phenotype, and varied degrees of malignant nature and prognosis among these subtypes have been shown.
METHODS: The subjects were 36 patients with surgically confirmed IPMNs, who underwent PJC preoperatively by endoscopic retrograde cholangiopancreatography. Histological subtyping of cytological samples with or without MUC stain (MUC1, MUC2, and MUC5AC) was compared with that of resected specimens.
RESULTS: Histologically, low-grade dysplasia was found in 4 patients, intermediate in 10, high grade in 11, and invasive carcinoma in 11. Gastric, intestinal, pancreatobiliary, and oncocytic subtypes corresponded to 16, 14, 5, and 1 patient, respectively. The rate of high-grade dysplasia (HGD) and/or invasive IPMNs was 25% for gastric subtype, 85.7% for intestinal subtype, and 100% for both pancreatobiliary and oncocytic subtypes, showing a significant correlation between histological subtype and rate of HGD and/or invasive IPMN (P < 0.01 for gastric vs nongastric).Histological subtype was successfully diagnosed by PJC in 42% (15/36) without MUC stain, and the rate was significantly improved to 89% (32/36) with MUC stain (P < 0.01). The sensitivity, specificity, and overall accuracy of PJC with MUC stain were 86%, 100%, and 94% for intestinal subtype, respectively. When cytological grade was combined with MUC stain, the diagnosis of HGD/invasive IPMN showed 77.2% sensitivity, 85.7% specificity, and 80.5% accuracy.
CONCLUSIONS: Preoperative PJC with MUC stain proved to be highly reliable for identifying the histological subtype of IPMN and may provide useful information for deciding surgical indication.

Entities:  

Mesh:

Year:  2013        PMID: 23364699     DOI: 10.1097/SLA.0b013e318281b824

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  10 in total

Review 1.  Natural History of Pancreatic Cysts.

Authors:  Alexander Larson; Richard S Kwon
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

2.  Confocal Endomicroscopy Characteristics of Different Intraductal Papillary Mucinous Neoplasm Subtypes.

Authors:  Amrit K Kamboj; John M Dewitt; Rohan M Modi; Darwin L Conwell; Somashekar G Krishna
Journal:  JOP       Date:  2017-05

Review 3.  International consensus on the management of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Masao Tanaka
Journal:  Ann Transl Med       Date:  2015-11

4.  Routine Cyst Fluid Cytology Is Not Indicated in the Evaluation of Pancreatic Cystic Lesions.

Authors:  Lawrence A Shirley; Jon Walker; Somashekar Krishna; Samer El-Dika; Peter Muscarella; E Christopher Ellison; Carl R Schmidt; Mark Bloomston
Journal:  J Gastrointest Surg       Date:  2016-05-26       Impact factor: 3.452

5.  Low interobserver agreement in cytology grading of mucinous pancreatic neoplasms.

Authors:  Carlie S Sigel; Marcia Edelweiss; Leung Chu Tong; Joanna Magda; Handy Oen; Keith M Sigel; Maureen F Zakowski
Journal:  Cancer Cytopathol       Date:  2014-10-29       Impact factor: 5.284

6.  Interobserver variability in intraductal papillary mucinous neoplasm subtypes and application of their mucin immunoprofiles.

Authors:  Heewon A Kwak; Xiuli Liu; Daniela S Allende; Rish K Pai; John Hart; Shu-Yuan Xiao
Journal:  Mod Pathol       Date:  2016-05-20       Impact factor: 7.842

Review 7.  Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s).

Authors:  Joseph Carmicheal; Asish Patel; Vipin Dalal; Pranita Atri; Amaninder S Dhaliwal; Uwe A Wittel; Mokenge P Malafa; Geoffrey Talmon; Benjamin J Swanson; Shailender Singh; Maneesh Jain; Sukhwinder Kaur; Surinder K Batra
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-10-30       Impact factor: 10.680

Review 8.  Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN.

Authors:  M Distler; D Aust; J Weitz; C Pilarsky; Robert Grützmann
Journal:  Biomed Res Int       Date:  2014-03-24       Impact factor: 3.411

9.  Diagnosis of pancreatic neoplasms using a novel method of DNA methylation analysis of mucin expression in pancreatic juice.

Authors:  Seiya Yokoyama; Sho Kitamoto; Michiyo Higashi; Yuko Goto; Taro Hara; Dai Ikebe; Taketo Yamaguchi; Yoshifumi Arisaka; Toru Niihara; Hiroto Nishimata; Sadao Tanaka; Kyoichi Takaori; Surinder K Batra; Suguru Yonezawa
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

Review 10.  Current roles of endoscopy in the management of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Masao Tanaka
Journal:  Dig Endosc       Date:  2015-02-05       Impact factor: 7.559

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.